Sevenum

EQS-News: Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.

Retrieved on: 
Friday, May 10, 2024
Smartphone, Pharmacy, QR, Patient, Sevenum, Online shopping

Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.

Key Points: 
  • Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
  • Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
  • Secure, easy and comfortable way to redeem e-prescriptions.
  • Olaf Heinrich, CEO of Redcare Pharmacy, comments: “With the launch of our eHealth-CardLink solution, patients can now optimally benefit from the convenience of a paperless, fully digitised prescription.

EQS-News: Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.

Retrieved on: 
Friday, May 3, 2024
CFO, Total, International, Depreciation, EUR, Pharmacy, DACH, Crown, Marketing, Growth, Sevenum, Lithium

Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin.

Key Points: 
  • Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin.
  • Non-Rx sales growth 20% to EUR 404M; Rx sales up 7% in Germany, following additional marketing and communication campaigns.
  • After depreciation of EUR 16.3 million (Q1 2023: EUR 12.1 million), EBIT was EUR -5.7 million, an improvement versus last year’s EUR -7.6 million.
  • The full year guidance provided on 5 March:
    Total sales increase to EUR 2.3-2.5 billion, a growth of 30% to 40%.

EQS-News: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.

Retrieved on: 
Friday, May 3, 2024
Pharmacy, PIN, EUR, Plasma protein binding, Prescription, Smartphone, QR, Patient, Redcare, Sevenum, Pharmaceutical industry

Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.

Key Points: 
  • Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
  • Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
  • Today, Redcare Pharmacy has successfully obtained the provider approval by the gematik for its eHealth-CardLink solution, while its development partner eHealth Experts simultaneously received the product approval.
  • Customers of online pharmacies will still be able to use the gematik app or scan the QR code on the printed prescription.

EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.

Retrieved on: 
Friday, May 3, 2024
Annual general meeting, CFO, CCO, Pharmacy, Growth, Development, Culture, Vorstand, Supervisory board, CIO, Sevenum, Management

Dirk Brüse and Lode Fastré new members of the Managing Board.

Key Points: 
  • Dirk Brüse and Lode Fastré new members of the Managing Board.
  • Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items.
  • Dirk Brüse and Lode Fastré new members of the Managing Board.
  • As long-standing members of Redcare Pharmacy´s Senior Management Dirk Brüse and Lode Fastré have been mentored by Stephan Weber and Marc Fischer for many years.

EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.

Retrieved on: 
Wednesday, April 10, 2024
Sevenum, EUR, DACH, Growth, ER-X, International, Education, Pharmacy, NFC, Marketing, Mobile phone

Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.

Key Points: 
  • Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
  • Redcare Pharmacy’s CEO, Olaf Heinrich comments: “We started the year very well, with strong sales growth accompanied by persistently high non-financial KPIs.
  • Non-Rx sales growth was 16.8% to EUR 297 million (Q1 2023: EUR 254 million), while prescription medication sales (Rx) rose by 348.3% to EUR 156 million.
  • Excluding MediService, Rx sales growth in DACH was 6.8% to EUR 37 million (Q1 2023: EUR 35 million).

EQS-News: Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.

Retrieved on: 
Wednesday, March 13, 2024
CFO, Pharmacy, International, Annual general meeting, PIN, NPS, DACH, Crown, Growth, Sevenum, ESG, Shop, Risk, Documentation, S&D, AA, EUR, Element, Galenica, Redcare, AGM, Patient, MSCI, AAA, Acceleration, NFC, Prescription, Research, Depreciation, Partnership, Lithium

Successful completion of a record year for Redcare Pharmacy: growth 49%, adj.

Key Points: 
  • Successful completion of a record year for Redcare Pharmacy: growth 49%, adj.
  • EBITDA margin 3% for full year 2023, +3.7pp vs. 2022, with major improvements in both DACH and International segments.
  • Full-year guidance for 2024: continuation of both fast sales growth (30-40%) and solidly positive margins (adj.
  • Following positive margins in all four quarters, (iii) the adjusted EBITDA margin for the full year was 3% (guidance range of 1.5% to 3%).

EQS-News: Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).

Retrieved on: 
Wednesday, March 13, 2024
Pharmacy, Marketing, Supervisory board, DACH, Culture, CCO, Sevenum, EUR, Redcare, AGM, CIO, Annual, Retail media, Development, DNA

Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).

Key Points: 
  • Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
  • Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
  • Dirk Brüse and Lode Fastré, both long-standing managers at Redcare Pharmacy, are to succeed Stephan Weber and Marc Fischer as CCO and CIO.
  • Today, the Supervisory Board of Redcare Pharmacy agreed to the early departure request of the Managing Board members and founders Stephan Weber (CCO) and Marc Fischer (CIO).

EQS-News: Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.

Retrieved on: 
Saturday, January 13, 2024
Record, DACH, Pharmacy, International, Sevenum, EUR, Annual report, Growth, Lithium

Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.

Key Points: 
  • Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
  • Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
  • Full year total sales EUR 1.8bn vs. guidance of EUR 1.7-1.8bn, a growth of 49%.
  • In full year 2023, growth in International stood at 31%, with sales at EUR 345 million (FY 2022: EUR 264 million).

EQS-News: Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.

Retrieved on: 
Tuesday, November 7, 2023
Pharmacy, Galenica, International, EBITDA, NPS, Acquisition, DACH, Growth, Marketing, Partnership, Depreciation, CFO, RDC, Investment, Saskatchewan River Sturgeon Management Board, EU, Sevenum, Conveyor system, Retail, Cryptocurrency, Film industry, Pharmaceutical industry, Lithium, Q3, EUR

Redcare Pharmacy: continued very fast growth combined with major margin lift; adj.

Key Points: 
  • Redcare Pharmacy: continued very fast growth combined with major margin lift; adj.
  • Redcare Pharmacy: continued very fast growth combined with major margin lift; adj.
  • EBITDA margin 3.2% in Q3 (9M 2.9%, up 4pp vs. last year’s 9M of -1%; driven by improvements across the business).
  • Redcare Pharmacy continued to record high, double-digit sales growth in Q3 while expanding margin performance.

EQS-News: Redcare Pharmacy continues to successfully grow fast in all its markets.

Retrieved on: 
Tuesday, October 17, 2023
Pharmacy, DACH, Sevenum, Growth, YTD, International, Soft drink, Film industry, Q3, Rx, EUR

Redcare Pharmacy continues to successfully grow fast in all its markets.

Key Points: 
  • Redcare Pharmacy continues to successfully grow fast in all its markets.
  • Redcare Pharmacy continues to successfully grow fast in all its markets.
  • Year to date, growth in the International segment stands at 29%, with sales at EUR 254 million (YTD 2022: EUR 197 million).
  • Redcare Pharmacy N.V. will release the full interim report for the third quarter of 2023 on 31 October 2023.